Dr. Katherine Talcott from the Cleveland Clinic shares a decision support tool that can reduce unnecessary opioid prescriptions by ophthalmologists.

Dr. Andrea Kossler from Byers Eye at Stanford discusses the implications of her new study on an important side effect.

Dr. Andrew Rong from the Bascom Palmer Eye Institute discusses his new study, Effects of mitomycin-C and 5-fluorouracil on ocular adnexal sebaceous carcinoma cells

Dr. Byron Lam from the Bascom Palmer Eye Institute discusses an exciting area of ophthalmic research

Dr. Ananth Sastry from VitreoRetinal Surgeons in Minnesota discusses his clinically relevant paper, Visual Outcomes in Eyes With Neovascular Glaucoma and Anterior Segment Neovascularization Without Glaucoma

Dr. David Brown from Retina Consultants of Texas discusses where brolucizumab fits in the treatment paradigm for diabetic macular edema based on two recent phase III trials.

Dr. Audina Berrocal from Bascom Palmer Eye Institute discusses findings from her American Ophthalmological Society Thesis.

Prof. Andrew Anderson from the Department of Optometry & Vision Sciences, Melbourne, Australia presents his recent randomized control trial on the utility of blue blocking lenses.

Dr. Aaron Lee from the University of Washington shares his insights on deep learning and biobanking as it relates to the current and future landscape of Ophthalmology. He discusses his recent article: "Automated Detection of Glaucoma With Interpretable Machine Learning Using Clinical Data and Multimodal Retinal Images".

Dr. Gary Holland interviews Dr. Douglas Jabs on the development and application of new classification criteria for common forms of uveitis.